General independent censoring in event-driven trials with staggered entry

Biometrics. 2023 Sep;79(3):1737-1748. doi: 10.1111/biom.13710. Epub 2022 Jul 19.

Abstract

Randomized clinical trials with time-to-event endpoints are frequently stopped after a prespecified number of events has been observed. This practice leads to dependent data and nonrandom censoring, which can in general not be solved by conditioning on the underlying baseline information. In case of staggered study entry, matters are complicated substantially. The present paper demonstrates that the study design at hand entails general independent censoring in the counting process sense, provided that the analysis is based on study time information only. To illustrate that the filtrations must not use abundant information, we simulated data of event-driven trials and evaluated them by means of Cox regression models with covariates for the calendar times. The Breslow curves of the cumulative baseline hazard showed considerable deviations, which implies that the analysis is disturbed by conditioning on the calendar time variables. A second simulation study further revealed that Efron's classical bootstrap, unlike the (martingale-based) wild bootstrap, may lead to biased results in the given setting, as the assumption of random censoring is violated. This is exemplified by an analysis of data on immunotherapy in patients with advanced, previously treated nonsmall cell lung cancer.

Keywords: counting process; event-driven trial; independent censoring; staggered study entry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Computer Simulation
  • Humans
  • Lung Neoplasms* / therapy
  • Proportional Hazards Models
  • Randomized Controlled Trials as Topic
  • Research Design
  • Time Factors